Twin Tree Management
SRPT icon

Twin Tree Management’s Sarepta Therapeutics SRPT Stock Holding History

Twin Tree Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-61,658
Closed -$7.5M – 1905
2024
Q4 		$7.5M Sell
61,658
-45,891
-43% -$5.62M 0.01% 804
2024
Q3 		$13.4M Buy
+107,549
New +$14.9M 0.03% 543
2024
Q1 		– Sell
-582
Closed -$56.1K – 1587
2023
Q4 		$56.1K Sell
582
-1,514
-72% -$145K ﹤0.01% 1285
2023
Q3 		$254K Buy
+2,096
New +$237K ﹤0.01% 1065
2020
Q2 		– Sell
-50,847
Closed -$4.97M – 1688
2020
Q1 		$4.97M Buy
+50,847
New +$5.81M 0.02% 488
2019
Q4 		– Sell
-113,106
Closed -$11.4M – 1458
2019
Q3 		$8.52M Buy
+113,106
New +$13.4M 0.03% 361

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Twin Tree Management's SRPT Position: Q1 2025 in Review

Twin Tree Management sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 61,658 shares — an estimated $7.5M sold.

Twin Tree Management first reported a position in SRPT in Q3 2019 and held it in 6 quarters. The position peaked at $13.4M in Q3 2024. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

  • Twin Tree Management reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Twin Tree Management sold 61,658 Sarepta Therapeutics shares in Q1 2025, an estimated $7.5M.
  • Twin Tree Management first reported a position in Sarepta Therapeutics in Q3 2019 and held it in 6 quarters.
  • Twin Tree Management's Sarepta Therapeutics position peaked at $13.4M in Q3 2024.
  • 430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Twin Tree Management's 13F filing for Q1 2025, filed 15 May 2025.